Riskpilot← Back to searchSign inGet full accessLYBE SCIENTIFIC AS
ASActiveOrg 926682520Laboratoriesenteret Erling Skjalgssons Gate 1, 7030 TrondheimResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20215 employees
Revenue 2024
NOK 4,9M
+130% vs 2023
EBITDA margin
39.6%
+225% vs 2023
Equity ratio
49.8%
Financial strength
Net profit 2024
NOK 87K
+103% vs 2023
| Revenue | NOK 4,9M | +130% |
| EBITDA | NOK 2M | +225% |
| Net profit | NOK 87K | +103% |
| Total assets | NOK 17,8M | +38% |
| Equity | NOK 8,8M | +70% |
| Employees | 5 | — |
Legal name
LYBE SCIENTIFIC AS
Org number
926682520
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3. mars 2021
Share capital
NOK 175 573
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskapets signatur innehas av to styremedlemmer i fellesskap.
Company purpose
Å utvikle og tilby ulike løsninger for prøvepreparering og analyse innenfor diagnostikkformål.
Address
Laboratoriesenteret Erling Skjalgssons Gate 1, 7030 Trondheim
Email
tonje@lybescientific.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 14 977 | 6 229 | 2 148 | 4 938 |
| Staff expenses | −795 | −2 372 | −230 | −0 |
| EBITDA | 3 366 | −508 | −1 570 | 1 956 |
| Depreciation & amort. | −155 | −290 | −785 | −1 453 |
| EBIT | 3 211 | −798 | −2 355 | 502 |
| Net financials | −6 | −103 | −28 | −415 |
| Profit before tax | 3 205 | −901 | −2 383 | 87 |
| Tax | 705 | −191 | 177 | −0 |
| Net profit | 2 500 | −710 | −2 559 | 87 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5 313 | 10 915 | 12 892 | 17 765 |
| Equity | 2 610 | 1 900 | 5 201 | 8 842 |
| Long-term debt | 714 | 4 576 | 3 550 | 3 667 |
| Short-term debt | 1 989 | 4 439 | 4 141 | 5 256 |
| Total debt | 2 703 | 9 015 | 7 691 | 8 923 |
EBITDA margin
39.6%
This company
15.8%
Market median
+151% vs market
20212024
Equity ratio
49.8%
This company
38.2%
Market median
+30% vs market
20212024
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20212024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20212024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20212024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-27 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TS Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2023 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 18.5% | 18.5% | 2024 | |
| Company | 11.01% | 11.01% | 2024 | |
| Company | 10.63% | 10.63% | 2024 | |
| Individual | 9.05% | 9.05% | 2024 | |
| Company | 8.59% | 8.59% | 2024 | |
| Company | 7.54% | 7.54% | 2024 | |
| Company | 5.51% | 5.51% | 2024 | |
| Company | 5.51% | 5.51% | 2024 | |
| Company | 4.87% | 4.87% | 2024 | |
| Company | 4.13% | 4.13% | 2024 | |
| Individual | 4.1% | 4.1% | 2024 | |
| Individual | 3.77% | 3.77% | 2024 | |
| Individual | 2.26% | 2.26% | 2024 | |
| Individual | 2.26% | 2.26% | 2024 | |
| Individual | 2.26% | 2.26% | 2024 | |
| Individual | 2.26% | 2.26% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LYBE SCIENTIFIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tonje Strømmen Steigedal | Chief Executive Officer | 0 companies |
| Eivind Andersen | Board of Directors | 0 companies |
| Mårten Wigstøl | Chairman | 0 companies |
| Gisle Østereng | Board of Directors | 0 companies |
| Sulalit Bandyopadhyay | Board of Directors | 0 companies |